Sculptor Capital LP Ocugen, Inc. Put Options Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $108,500 - $192,200	-62,000 Reduced 16.48%	314,200 $559,000
Q1 2022 May 13, 2022	SELL	$2.34 - $4.72 $1.49 Million - $3 Million	-635,600 Reduced 62.82%	376,200 $1.24 Million
Q4 2021 Feb 11, 2022	BUY	$4.38 - $15.67 $289,956 - $1.04 Million	66,200 Added 7.0%	1,011,800 $4.6 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $5.22 Million - $14.8 Million	945,600 New	945,600 $7.59 Million

125

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $197M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.